AGEN · Agenus Inc
$7.32
+0.32 (+4.57%)
At close · Aug 14
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the timing and completion of these transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 7, 2026
Market Cap
$329.55M
Shares
45.02M
Agenus Inc Earnings Call Transcripts
Every quarterly earnings call for Agenus Inc (AGEN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲95%
$20.93M
−$49.23M
'22 Q2
22-08-09
▼91%
$22.77M
−$56.72M
'22 Q3
22-11-08
▲40.1%
$28.39M
−$74.10M
'22 Q4
23-03-14
▼11.7%
$22.90M
−$70.89M
'23 Q1
23-05-09
▲6.8%
$24.31M
−$64.53M
'23 Q3
23-11-07
▲195.2%
$83.80M
−$48.58M
'23 Q4
24-03-14
▲22.3%
$28.00M
−$63.45M
'24 Q1
24-05-07
▼7.1%
$23.51M
−$54.80M
'24 Q2
24-08-08
▲3.3%
$25.11M
−$67.21M
'24 Q3
24-11-12
▼68%
$26.84M
−$46.81M
'24 Q4
25-03-11
▼14.1%
$24.07M
−$26.37M
'25 Q1
25-05-12
▲9.3%
$25.69M
−$30.01M
'25 Q2
25-08-27
▲20.4%
$30.23M
$63.91M
'25 Q3
25-12-03
▲27.5%
$34.20M
−$10.61M
'25 Q4
26-03-31
▲40.2%
$33.74M
$39.21M
'26 Q1
26-05-11
LATEST
▲34.4%
$34.52M
−$567,000
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Agenus Q2 2026 Earnings
Revenue
$34.52M
▲ 34.4% YoY Diluted EPS
$-0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-11
Agenus Inc Q1 FY2026 Earnings Call
Revenue
$33.74M
▲ 40.2% YoY Diluted EPS
$1.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Agenus Inc Q4 FY2025 Earnings Call
Revenue
$34.20M*
▲ 27.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-12-03
Agenus Inc Q3 FY2025 Earnings Call
Revenue
$30.23M
▲ 20.4% YoY Diluted EPS
$1.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-27
Agenus Inc Q2 FY2025 Earnings Call
Confident tone
BOT/BAL immunotherapy efficacy in colorectal cancer
Regulatory challenges and FDA delays
Phase III trial with CCTG
Revenue
$25.69M
▲ 9.3% YoY Diluted EPS
$-1.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Agenus Inc Q1 FY2025 Earnings Call
Confident tone
BOT/BAL clinical data
FDA and regulatory environment
Colorectal cancer unmet need
Revenue
$24.07M
▼ 14.1% YoY Diluted EPS
$-1.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Agenus Inc Q4 FY2024 Earnings Call
Confident tone
BOT/BAL clinical activity in colorectal cancer
Organ-sparing potential (rectal/colon cancer)
Non-core asset monetization
Revenue
$26.84M*
▼ 68% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Agenus Inc Q3 FY2024 Earnings Call
Positive tone
BOT/BAL clinical data in MSS colorectal cancer
Upcoming data presentations and pipeline readouts
Phase 3 design and regulatory feedback
Revenue
$25.11M
▲ 3.3% YoY Diluted EPS
$-3.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Agenus Inc Q2 FY2024 Earnings Call
Confident tone
BOT/BAL in colorectal cancer
FDA regulatory interaction and accelerated filing
Phase II data and upcoming November dataset
Revenue
$23.51M
▼ 7.1% YoY Diluted EPS
$-2.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Agenus Inc Q1 FY2024 Earnings Call
Positive tone
BOT/BAL lead program in colorectal cancer
Pipeline expansion across other tumors
Regulatory pathway and FDA alignment
Revenue
$28.00M
▲ 22.3% YoY Diluted EPS
$-3.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
Agenus Inc Q4 FY2023 Earnings Call
Confident tone
Regulatory pathway and FDA
BOT/BAL program and data
Phase 2 trial readout timing
Revenue
$83.80M*
▲ 195.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Agenus Inc Q3 FY2023 Earnings Call
Revenue
$24.31M
▲ 6.8% YoY Diluted EPS
$-3.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Agenus Inc Q1 FY2023 Earnings Call
Revenue
$22.90M
▼ 11.7% YoY Diluted EPS
$-4.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-14
Agenus Inc Q4 FY2022 Earnings Call
Revenue
$28.39M*
▲ 40.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Agenus Inc Q3 FY2022 Earnings Call
Revenue
$22.77M
▼ 91% YoY Diluted EPS
$-3.80
▼ 126.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Agenus Inc Q2 FY2022 Earnings Call
Revenue
$20.93M
▲ 95% YoY Diluted EPS
$-3.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-06-29
Agenus Inc Q1 FY2022 Earnings Call
Revenue
$25.94M
▲ 121.4% YoY Diluted EPS
$-3.80
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Agenus Inc Q4 FY2021 Earnings Call
Revenue
$20.26M*
▼ 35.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Agenus Inc Q3 FY2021 Earnings Call
Revenue
$252.95M
▲ 1605.5% YoY Diluted EPS
$14.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Agenus Inc Q2 FY2021 Earnings Call
Revenue
$10.73M
▼ 60.2% YoY Diluted EPS
$-7.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Agenus Inc Q1 FY2021 Earnings Call
Revenue
$11.72M
▼ 22.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-15
Agenus Inc Q4 FY2020 Earnings Call
Revenue
$31.27M
▼ 9.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-16
Agenus Inc Q3 FY2020 Earnings Call
Revenue
$14.83M
▼ 25.6% YoY Diluted EPS
$-5.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Agenus Inc Q2 FY2020 Earnings Call
Revenue
$26.95M
▲ 71.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Agenus Inc Q1 FY2020 Earnings Call
Revenue
$15.13M
▼ 81.1% YoY Diluted EPS
$-6.08
▼ 358.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Agenus Inc Q4 FY2019 Earnings Call
Revenue
$34.50M
▲ 434.8% YoY Diluted EPS
$-4.32
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 earnings calls
Key facts
CIK
1098972
CUSIP
00847G804
13F (30d)
107 filings
104 filers
Visit website
Investor relations